ID   PNPH_HUMAN              Reviewed;         289 AA.
AC   P00491; B2R8S5; D3DS00; Q15160; Q5PZ03;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   10-MAY-2017, entry version 190.
DE   RecName: Full=Purine nucleoside phosphorylase;
DE            Short=PNP;
DE            EC=2.4.2.1;
DE   AltName: Full=Inosine phosphorylase;
DE   AltName: Full=Inosine-guanosine phosphorylase;
GN   Name=PNP; Synonyms=NP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-51.
RX   PubMed=6087295; DOI=10.1093/nar/12.14.5779;
RA   Williams S.R., Goddard J.M., Martin D.W. Jr.;
RT   "Human purine nucleoside phosphorylase cDNA sequence and genomic clone
RT   characterization.";
RL   Nucleic Acids Res. 12:5779-5787(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT PNPD LYS-89, AND VARIANT
RP   SER-51.
RX   PubMed=3029074;
RA   Williams S.R., Gekeler V., McIvor R.S., Martin D.W. Jr.;
RT   "A human purine nucleoside phosphorylase deficiency caused by a single
RT   base change.";
RL   J. Biol. Chem. 262:2332-2338(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-51.
RX   PubMed=12928150; DOI=10.1289/ehp.6420;
RA   Yu L., Kalla K., Guthrie E., Vidrine A., Klimecki W.T.;
RT   "Genetic variation in genes associated with arsenic metabolism:
RT   glutathione S-transferase omega 1-1 and purine nucleoside
RT   phosphorylase polymorphisms in European and indigenous Americans.";
RL   Environ. Health Perspect. 111:1421-1427(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-51.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-22; 42-58; 68-76; 96-148; 212-229; 235-265 AND
RP   271-287, ACETYLATION AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (FEB-2006) to UniProtKB.
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=22509282; DOI=10.1371/journal.pone.0034237;
RA   von Lohneysen K., Scott T.M., Soldau K., Xu X., Friedman J.S.;
RT   "Assessment of the red cell proteome of young patients with
RT   unexplained hemolytic anemia by two-dimensional differential in-gel
RT   electrophoresis (DIGE).";
RL   PLoS ONE 7:E34237-E34237(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-251, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS), AND FUNCTION.
RX   PubMed=2104852;
RA   Ealick S.E., Rule S.A., Carter D.C., Greenhough T.J., Babu Y.S.,
RA   Cook W.J., Habash J., Helliwell J.R., Stoeckler J.D., Parks R.E. Jr.,
RA   Chen S.-F., Bugg C.E.;
RT   "Three-dimensional structure of human erythrocytic purine nucleoside
RT   phosphorylase at 3.2-A resolution.";
RL   J. Biol. Chem. 265:1812-1820(1990).
RN   [17]
RP   VARIANT SER-51, AND VARIANTS PNPD GLY-128 AND PRO-234.
RX   PubMed=1384322;
RA   Aust M.R., Andrews L.G., Barrett M.J., Norby-Slycord C.J.,
RA   Markert M.L.;
RT   "Molecular analysis of mutations in a patient with purine nucleoside
RT   phosphorylase deficiency.";
RL   Am. J. Hum. Genet. 51:763-772(1992).
RN   [18]
RP   VARIANT PNPD CYS-192.
RX   PubMed=8931706; DOI=10.1007/s004390050290;
RA   Pannicke U., Tuchschmid P., Friedrich W., Bartram C.R., Schwarz K.;
RT   "Two novel missense and frameshift mutations in exons 5 and 6 of the
RT   purine nucleoside phosphorylase (PNP) gene in a severe combined
RT   immunodeficiency (SCID) patient.";
RL   Hum. Genet. 98:706-709(1996).
CC   -!- FUNCTION: The purine nucleoside phosphorylases catalyze the
CC       phosphorolytic breakdown of the N-glycosidic bond in the beta-
CC       (deoxy)ribonucleoside molecules, with the formation of the
CC       corresponding free purine bases and pentose-1-phosphate.
CC       {ECO:0000269|PubMed:2104852}.
CC   -!- CATALYTIC ACTIVITY: Purine nucleoside + phosphate = purine +
CC       alpha-D-ribose 1-phosphate.
CC   -!- PATHWAY: Purine metabolism; purine nucleoside salvage.
CC   -!- SUBUNIT: Homotrimer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.
CC       Cytoplasm {ECO:0000269|PubMed:22509282}.
CC   -!- TISSUE SPECIFICITY: Expressed in red blood cells; overexpressed in
CC       red blood cells (cytoplasm) of patients with hereditary non-
CC       spherocytic hemolytic anemia of unknown etiology.
CC       {ECO:0000269|PubMed:22509282}.
CC   -!- DISEASE: Purine nucleoside phosphorylase deficiency (PNPD)
CC       [MIM:613179]: A disorder that interrupts both the catabolism of
CC       inosine into hypoxanthine and guanosine into guanine, and leads to
CC       the accumulation of guanosine, inosine, and their deoxified by-
CC       products. The main clinical presentation is recurrent infections
CC       due to severe T-cell immunodeficiency. Some patients also have
CC       neurologic impairment. {ECO:0000269|PubMed:1384322,
CC       ECO:0000269|PubMed:3029074, ECO:0000269|PubMed:8931706}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the PNP/MTAP phosphorylase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NPbase; Note=NP mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/NPbase/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00737; CAA25320.1; -; mRNA.
DR   EMBL; M13953; AAA36460.1; -; Genomic_DNA.
DR   EMBL; J02672; AAA36460.1; JOINED; Genomic_DNA.
DR   EMBL; M13951; AAA36460.1; JOINED; Genomic_DNA.
DR   EMBL; M13952; AAA36460.1; JOINED; Genomic_DNA.
DR   EMBL; AY817667; AAV68044.1; -; Genomic_DNA.
DR   EMBL; AK313490; BAG36272.1; -; mRNA.
DR   EMBL; CR407607; CAG28535.1; -; mRNA.
DR   EMBL; CH471078; EAW66458.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66459.1; -; Genomic_DNA.
DR   EMBL; BC104206; AAI04207.1; -; mRNA.
DR   EMBL; BC104207; AAI04208.1; -; mRNA.
DR   EMBL; BC106074; AAI06075.1; -; mRNA.
DR   CCDS; CCDS9552.1; -.
DR   PIR; A00578; PHHUPN.
DR   RefSeq; NP_000261.2; NM_000270.3.
DR   UniGene; Hs.75514; -.
DR   PDB; 1M73; X-ray; 2.30 A; E=2-289.
DR   PDB; 1PF7; X-ray; 2.60 A; E=1-289.
DR   PDB; 1PWY; X-ray; 2.80 A; E=2-289.
DR   PDB; 1RCT; X-ray; 2.80 A; E=2-289.
DR   PDB; 1RFG; X-ray; 2.90 A; E=2-289.
DR   PDB; 1RR6; X-ray; 2.50 A; A=1-289.
DR   PDB; 1RSZ; X-ray; 2.20 A; A=1-289.
DR   PDB; 1RT9; X-ray; 2.30 A; A=1-289.
DR   PDB; 1ULA; X-ray; 2.75 A; A=1-289.
DR   PDB; 1ULB; X-ray; 2.75 A; A=1-289.
DR   PDB; 1V2H; X-ray; 2.70 A; E=2-289.
DR   PDB; 1V3Q; X-ray; 2.80 A; E=2-289.
DR   PDB; 1V41; X-ray; 2.85 A; E=2-289.
DR   PDB; 1V45; X-ray; 2.86 A; E=2-289.
DR   PDB; 1YRY; X-ray; 2.80 A; E=1-289.
DR   PDB; 2A0W; X-ray; 2.28 A; A=1-289.
DR   PDB; 2A0X; X-ray; 2.28 A; A=1-289.
DR   PDB; 2A0Y; X-ray; 2.28 A; A=1-289.
DR   PDB; 2OC4; X-ray; 2.59 A; A=1-289.
DR   PDB; 2OC9; X-ray; 2.59 A; A=1-289.
DR   PDB; 2ON6; X-ray; 2.50 A; A=1-289.
DR   PDB; 2Q7O; X-ray; 2.90 A; E=1-289.
DR   PDB; 3BGS; X-ray; 2.10 A; A=1-289.
DR   PDB; 3D1V; X-ray; 2.70 A; A=1-289.
DR   PDB; 3GB9; X-ray; 2.30 A; A/B/C=1-289.
DR   PDB; 3GGS; X-ray; 2.52 A; A/B/C=1-289.
DR   PDB; 3INY; X-ray; 2.75 A; A=1-289.
DR   PDB; 3K8O; X-ray; 2.40 A; E/Q/S/T/U/Y=1-289.
DR   PDB; 3K8Q; X-ray; 2.50 A; A=1-289.
DR   PDB; 3PHB; X-ray; 2.30 A; E/Q/S/T/U/Y=1-289.
DR   PDB; 4EAR; X-ray; 1.70 A; A/B/C=1-289.
DR   PDB; 4EB8; X-ray; 2.30 A; A/B/C=1-289.
DR   PDB; 4ECE; X-ray; 2.60 A; A/B/C/D/E/F=1-289.
DR   PDB; 4GKA; X-ray; 2.20 A; A/B/C/D/E/F=1-289.
DR   PDB; 5ETJ; X-ray; 2.30 A; A/B/C/D/E/F=1-289.
DR   PDBsum; 1M73; -.
DR   PDBsum; 1PF7; -.
DR   PDBsum; 1PWY; -.
DR   PDBsum; 1RCT; -.
DR   PDBsum; 1RFG; -.
DR   PDBsum; 1RR6; -.
DR   PDBsum; 1RSZ; -.
DR   PDBsum; 1RT9; -.
DR   PDBsum; 1ULA; -.
DR   PDBsum; 1ULB; -.
DR   PDBsum; 1V2H; -.
DR   PDBsum; 1V3Q; -.
DR   PDBsum; 1V41; -.
DR   PDBsum; 1V45; -.
DR   PDBsum; 1YRY; -.
DR   PDBsum; 2A0W; -.
DR   PDBsum; 2A0X; -.
DR   PDBsum; 2A0Y; -.
DR   PDBsum; 2OC4; -.
DR   PDBsum; 2OC9; -.
DR   PDBsum; 2ON6; -.
DR   PDBsum; 2Q7O; -.
DR   PDBsum; 3BGS; -.
DR   PDBsum; 3D1V; -.
DR   PDBsum; 3GB9; -.
DR   PDBsum; 3GGS; -.
DR   PDBsum; 3INY; -.
DR   PDBsum; 3K8O; -.
DR   PDBsum; 3K8Q; -.
DR   PDBsum; 3PHB; -.
DR   PDBsum; 4EAR; -.
DR   PDBsum; 4EB8; -.
DR   PDBsum; 4ECE; -.
DR   PDBsum; 4GKA; -.
DR   PDBsum; 5ETJ; -.
DR   ProteinModelPortal; P00491; -.
DR   SMR; P00491; -.
DR   BioGrid; 110921; 38.
DR   DIP; DIP-50406N; -.
DR   IntAct; P00491; 13.
DR   MINT; MINT-1375849; -.
DR   STRING; 9606.ENSP00000354532; -.
DR   BindingDB; P00491; -.
DR   ChEMBL; CHEMBL4338; -.
DR   DrugBank; DB03609; 3-Deoxyguanosine.
DR   DrugBank; DB01667; 8-azaguanine.
DR   DrugBank; DB02796; 9-Deazainosine.
DR   DrugBank; DB00242; Cladribine.
DR   DrugBank; DB00900; Didanosine.
DR   DrugBank; DB02377; Guanine.
DR   DrugBank; DB02857; Guanosine.
DR   DrugBank; DB04076; Hypoxanthine.
DR   DrugBank; DB02230; Immucillin-G.
DR   DrugBank; DB04335; Inosine.
DR   DrugBank; DB03881; MT-Immucillin-H.
DR   DrugBank; DB02568; Peldesine.
DR   DrugBank; DB03101; Ribose-1-Phosphate.
DR   GuidetoPHARMACOLOGY; 2841; -.
DR   iPTMnet; P00491; -.
DR   PhosphoSitePlus; P00491; -.
DR   SwissPalm; P00491; -.
DR   BioMuta; PNP; -.
DR   DMDM; 108935929; -.
DR   OGP; P00491; -.
DR   EPD; P00491; -.
DR   PaxDb; P00491; -.
DR   PeptideAtlas; P00491; -.
DR   PRIDE; P00491; -.
DR   TopDownProteomics; P00491; -.
DR   Ensembl; ENST00000361505; ENSP00000354532; ENSG00000198805.
DR   GeneID; 4860; -.
DR   KEGG; hsa:4860; -.
DR   CTD; 4860; -.
DR   DisGeNET; 4860; -.
DR   GeneCards; PNP; -.
DR   HGNC; HGNC:7892; PNP.
DR   HPA; HPA001625; -.
DR   MalaCards; PNP; -.
DR   MIM; 164050; gene.
DR   MIM; 613179; phenotype.
DR   neXtProt; NX_P00491; -.
DR   OpenTargets; ENSG00000198805; -.
DR   Orphanet; 760; Purine nucleoside phosphorylase deficiency.
DR   PharmGKB; PA31694; -.
DR   eggNOG; KOG3984; Eukaryota.
DR   eggNOG; COG0005; LUCA.
DR   GeneTree; ENSGT00550000074740; -.
DR   HOVERGEN; HBG002460; -.
DR   InParanoid; P00491; -.
DR   KO; K03783; -.
DR   OMA; MENGYTY; -.
DR   OrthoDB; EOG091G0GEE; -.
DR   PhylomeDB; P00491; -.
DR   TreeFam; TF300049; -.
DR   BioCyc; MetaCyc:HS02151-MONOMER; -.
DR   BRENDA; 2.4.2.1; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-74217; Purine salvage.
DR   Reactome; R-HSA-74259; Purine catabolism.
DR   SABIO-RK; P00491; -.
DR   SignaLink; P00491; -.
DR   UniPathway; UPA00606; -.
DR   ChiTaRS; PNP; human.
DR   EvolutionaryTrace; P00491; -.
DR   GeneWiki; Purine_nucleoside_phosphorylase; -.
DR   GenomeRNAi; 4860; -.
DR   PRO; PR:P00491; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000198805; -.
DR   CleanEx; HS_NP; -.
DR   ExpressionAtlas; P00491; baseline and differential.
DR   Genevisible; P00491; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005622; C:intracellular; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0001882; F:nucleoside binding; IDA:UniProtKB.
DR   GO; GO:0042301; F:phosphate ion binding; IDA:UniProtKB.
DR   GO; GO:0002060; F:purine nucleobase binding; IDA:UniProtKB.
DR   GO; GO:0004731; F:purine-nucleoside phosphorylase activity; IDA:UniProtKB.
DR   GO; GO:0006955; P:immune response; IMP:UniProtKB.
DR   GO; GO:0006148; P:inosine catabolic process; IDA:MGI.
DR   GO; GO:0070970; P:interleukin-2 secretion; IMP:UniProtKB.
DR   GO; GO:0034356; P:NAD biosynthesis via nicotinamide riboside salvage pathway; IGI:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006738; P:nicotinamide riboside catabolic process; IDA:UniProtKB.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; IDA:UniProtKB.
DR   GO; GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IDA:MGI.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:MGI.
DR   GO; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome.
DR   GO; GO:0043101; P:purine-containing compound salvage; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IDA:UniProtKB.
DR   GO; GO:0034418; P:urate biosynthetic process; IDA:MGI.
DR   InterPro; IPR000845; Nucleoside_phosphorylase_d.
DR   InterPro; IPR011270; Pur_Nuc_Pase_Ino/Guo-sp.
DR   InterPro; IPR011268; Purine_phosphorylase.
DR   InterPro; IPR018099; Purine_phosphorylase-2_CS.
DR   PANTHER; PTHR11904; PTHR11904; 1.
DR   Pfam; PF01048; PNP_UDP_1; 1.
DR   PIRSF; PIRSF000477; PurNPase; 1.
DR   SUPFAM; SSF53167; SSF53167; 1.
DR   TIGRFAMs; TIGR01700; PNPH; 1.
DR   TIGRFAMs; TIGR01697; PNPH-PUNA-XAPA; 1.
DR   PROSITE; PS01240; PNP_MTAP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease mutation; Glycosyltransferase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    289       Purine nucleoside phosphorylase.
FT                                /FTId=PRO_0000184536.
FT   REGION       84     86       Phosphate binding.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING      33     33       Phosphate.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING      64     64       Phosphate.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING     116    116       Phosphate; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING     201    201       Purine nucleoside.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING     220    220       Phosphate.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   BINDING     243    243       Purine nucleoside.
FT                                {ECO:0000250|UniProtKB:P55859}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES     251    251       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      51     51       G -> S (in dbSNP:rs1049564).
FT                                {ECO:0000269|PubMed:12928150,
FT                                ECO:0000269|PubMed:1384322,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:3029074,
FT                                ECO:0000269|PubMed:6087295}.
FT                                /FTId=VAR_002243.
FT   VARIANT      89     89       E -> K (in PNPD; dbSNP:rs104894453).
FT                                {ECO:0000269|PubMed:3029074}.
FT                                /FTId=VAR_002244.
FT   VARIANT     128    128       D -> G (in PNPD; dbSNP:rs104894450).
FT                                {ECO:0000269|PubMed:1384322}.
FT                                /FTId=VAR_002245.
FT   VARIANT     174    174       A -> P (in PNPD; dbSNP:rs104894454).
FT                                /FTId=VAR_002246.
FT   VARIANT     192    192       Y -> C (in PNPD; dbSNP:rs104894452).
FT                                {ECO:0000269|PubMed:8931706}.
FT                                /FTId=VAR_010653.
FT   VARIANT     234    234       R -> P (in PNPD; dbSNP:rs104894451).
FT                                {ECO:0000269|PubMed:1384322}.
FT                                /FTId=VAR_002247.
FT   HELIX         7     20       {ECO:0000244|PDB:4EAR}.
FT   STRAND       26     31       {ECO:0000244|PDB:4EAR}.
FT   HELIX        36     41       {ECO:0000244|PDB:4EAR}.
FT   STRAND       43     49       {ECO:0000244|PDB:4EAR}.
FT   HELIX        50     52       {ECO:0000244|PDB:4EAR}.
FT   STRAND       53     55       {ECO:0000244|PDB:1PWY}.
FT   HELIX        62     65       {ECO:0000244|PDB:3BGS}.
FT   STRAND       67     73       {ECO:0000244|PDB:4EAR}.
FT   STRAND       76     83       {ECO:0000244|PDB:4EAR}.
FT   HELIX        87     89       {ECO:0000244|PDB:4EAR}.
FT   HELIX        93     96       {ECO:0000244|PDB:4EAR}.
FT   HELIX        98    106       {ECO:0000244|PDB:4EAR}.
FT   STRAND      110    119       {ECO:0000244|PDB:4EAR}.
FT   STRAND      121    123       {ECO:0000244|PDB:1V2H}.
FT   STRAND      129    137       {ECO:0000244|PDB:4EAR}.
FT   HELIX       138    141       {ECO:0000244|PDB:4EAR}.
FT   TURN        153    155       {ECO:0000244|PDB:4EAR}.
FT   TURN        163    166       {ECO:0000244|PDB:1V41}.
FT   HELIX       168    179       {ECO:0000244|PDB:4EAR}.
FT   TURN        180    182       {ECO:0000244|PDB:1RSZ}.
FT   STRAND      188    194       {ECO:0000244|PDB:4EAR}.
FT   STRAND      197    199       {ECO:0000244|PDB:1M73}.
FT   HELIX       203    211       {ECO:0000244|PDB:4EAR}.
FT   STRAND      215    221       {ECO:0000244|PDB:4EAR}.
FT   HELIX       222    230       {ECO:0000244|PDB:4EAR}.
FT   STRAND      234    244       {ECO:0000244|PDB:4EAR}.
FT   STRAND      248    250       {ECO:0000244|PDB:4EAR}.
FT   HELIX       257    266       {ECO:0000244|PDB:4EAR}.
FT   HELIX       268    280       {ECO:0000244|PDB:4EAR}.
FT   TURN        285    287       {ECO:0000244|PDB:1M73}.
SQ   SEQUENCE   289 AA;  32118 MW;  91622FB1D26479D3 CRC64;
     MENGYTYEDY KNTAEWLLSH TKHRPQVAII CGSGLGGLTD KLTQAQIFDY GEIPNFPRST
     VPGHAGRLVF GFLNGRACVM MQGRFHMYEG YPLWKVTFPV RVFHLLGVDT LVVTNAAGGL
     NPKFEVGDIM LIRDHINLPG FSGQNPLRGP NDERFGDRFP AMSDAYDRTM RQRALSTWKQ
     MGEQRELQEG TYVMVAGPSF ETVAECRVLQ KLGADAVGMS TVPEVIVARH CGLRVFGFSL
     ITNKVIMDYE SLEKANHEEV LAAGKQAAQK LEQFVSILMA SIPLPDKAS
//
